|
Current Opinion in Drug Discovery & Development
|
| | |  | Archive |
|
|
| | | |
|
| | Current Opinion in Drug Discovery & Development, Volume 5 |
|
| |
Paper alert
J Hirst, P Norman
Current Opinion in Drug Discovery & Development 2002, 5:1-19 (15 January2002)
[PDF]
Patent alert
B Swords
Current Opinion in Drug Discovery & Development 2002, 5:20-28 (15January2002)
[PDF]
The chemistry of metabolic and toxicological processes
D Cavalla
Current Opinion in Drug Discovery & Development 2002, 5:29-30 (15January2002)
[PDF] [PubMed] [Related articles]
The chemistry of metabolic and toxicological processes
DE Johnson, DA Smith, BK Park
Current Opinion in Drug Discovery & Development 2002, 5:31-32 (15January2002)
[PDF]
High-throughput and in silico techniques in drug metabolism and pharmacokinetics
H van de Waterbeemd
Current Opinion in Drug Discovery & Development 2002, 5:33-43 (15January2002)
[PDF] [PubMed] [Related articles]
Evolutionary computational methods to predict oral bioavailability QSPRs
W Bains, R Gilbert, L Sviridenko, JM Gascon, R Scoffin, K Birchall, I Harvey, J Caldwell
Current Opinion in Drug Discovery & Development 2002, 5:44-51 (15January2002)
[PDF] [PubMed] [Related articles]
Automated sample preparation and LC-MS for high-throughput ADME quantification
D O'Connor
Current Opinion in Drug Discovery & Development 2002, 5:52-58 (15January2002)
[PDF] [PubMed] [Related articles]
Intravenous administration of poorly soluble new drug entities in early drug discovery: The potential impact of formulation on pharmacokinetic parameters
B Bittner, RJ Mountfield
Current Opinion in Drug Discovery & Development 2002, 5:59-71 (15January2002)
[PDF] [PubMed] [Related articles]
Increasing throughput in lead optimization in vivo toxicity screens
V Meador, W Jordan, J Zimmermann
Current Opinion in Drug Discovery & Development 2002, 5:72-78 (15January2002)
[PDF] [PubMed] [Related articles]
Gene expression profiling for pharmaceutical toxicology screening
PJ Bugelski
Current Opinion in Drug Discovery & Development 2002, 5:79-89 (15January2002)
[PDF] [PubMed] [Related articles]
Transcriptomics in predictive toxicology
T Storck, Brevern MC von, CK Behrens, J Scheel, A Bach
Current Opinion in Drug Discovery & Development 2002, 5:90-97 (15January2002)
[PDF] [PubMed] [Related articles]
Analysis of gene and protein expression for drug mode of toxicity
LM Furness
Current Opinion in Drug Discovery & Development 2002, 5:98-103 (15January2002)
[PDF] [PubMed] [Related articles]
Toxicophores: Groups and metabolic routes associated with increased safety risk
DP Williams, DJ Naisbitt
Current Opinion in Drug Discovery & Development 2002, 5:104-115 (15January2002)
[PDF] [PubMed] [Related articles]
Towards a drug concentration effect relationship for QT prolongation and torsades de pointes
R Webster, D Leishman, D Walker
Current Opinion in Drug Discovery & Development 2002, 5:116-126 (15January2002)
[PDF] [PubMed] [Related articles]
Models for profiling the potential QT prolongation risk of drugs
AL Muzikant, RC Penland
Current Opinion in Drug Discovery & Development 2002, 5:127-135 (15January2002)
[PDF] [PubMed] [Related articles]
Improving structure-linked access to publicly available chemical toxicity information
AM Richard, CR Williams, NF Cariello
Current Opinion in Drug Discovery & Development 2002, 5:136-143 (15January2002)
[PDF] [PubMed] [Related articles]
Genotype/phenotype comparisons: A probe for the effect of disease progression on drug metabolism
ML Williams, IW Wainer
Current Opinion in Drug Discovery & Development 2002, 5:144-149 (15January2002)
[PDF] [PubMed] [Related articles]
Structural insights into the promiscuity and function of the human pregnane X receptor
RE Watkins, SM Noble, MR Redinbo
Current Opinion in Drug Discovery & Development 2002, 5:150 (15January2002)
[PDF] [PubMed] [Related articles]
Paper alert
J Hirst, P Norman, DP Rotella
Current Opinion in Drug Discovery & Development 2002, 5:159-177 (12March2002)
[PDF]
Patent alert
B Swords
Current Opinion in Drug Discovery & Development 2002, 5:178-188 (12March2002)
[PDF]
The chemistry of biological products.
D Cavalla
Current Opinion in Drug Discovery & Development 2002, 5:189-190 (12March2002)
[PDF] [PubMed] [Related articles]
The chemistry of biological processes.
J McAlpine, K Culver, D Ecker
Current Opinion in Drug Discovery & Development 2002, 5:191-193 (12March2002)
[PDF]
Live bacteria as anticancer agents and tumor-selective protein delivery vectors.
D Bermudes, L Zheng, IC King
Current Opinion in Drug Discovery & Development 2002, 5:194-199 (12March2002)
[PDF] [PubMed] [Related articles]
The genus Bifidobacterium for cancer gene therapy.
M Fujimori, J Amano, S Taniguchi
Current Opinion in Drug Discovery & Development 2002, 5:200-203 (12March2002)
[PDF] [PubMed] [Related articles]
Recombinant antibodies for the selective targeting of tumor neovasculature.
F Viti, L Giovannoni, D Neri
Current Opinion in Drug Discovery & Development 2002, 5:204-213 (12March2002)
[PDF] [PubMed] [Related articles]
Inhibitors of growth factor receptor kinase-dependent signaling pathways in anticancer chemotherapy - clinical progress.
P Renhowe
Current Opinion in Drug Discovery & Development 2002, 5:214-224 (12March2002)
[PDF] [PubMed] [Related articles]
Current progress on farnesyl protein transferase inhibitors.
SB Singh, RB Lingham
Current Opinion in Drug Discovery & Development 2002, 5:225-244 (12March2002)
[PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Recent developments in peptide-based cancer therapeutics.
A Sehgal
Current Opinion in Drug Discovery & Development 2002, 5:245-250 (12March2002)
[PDF] [PubMed] [Related articles]
The cyclotides: Novel macrocyclic peptides as scaffolds in drug design.
DJ Craik, S Simonsen, NL Daly
Current Opinion in Drug Discovery & Development 2002, 5:251-260 (12March2002)
[PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Therapeutic applications of guanylate cyclase-C receptor agonists.
K Shailubhai
Current Opinion in Drug Discovery & Development 2002, 5:261-268 (12March2002)
[PDF] [PubMed] [Related articles]
Bacterial toxins as versatile delivery vehicles.
L deHaan, TR Hirst
Current Opinion in Drug Discovery & Development 2002, 5:269-278 (12March2002)
[PDF] [PubMed] [Related articles]
Drug delivery systems based on sugar-macromolecule conjugates.
BG Davis, MA Robinson
Current Opinion in Drug Discovery & Development 2002, 5:279-288 (12March2002)
[PDF] [PubMed] [Related articles]
Use of HSV vectors to modify the nervous system.
JC Glorioso, DJ Fink
Current Opinion in Drug Discovery & Development 2002, 5:289-295 (12March2002)
[PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Plant cell cultures as a source of bioactive small molecules.
AM Stafford
Current Opinion in Drug Discovery & Development 2002, 5:296-303 (12March2002)
[PDF] [PubMed] [Related articles]
Mother nature's combinatorial libraries; their influence on the synthesis of drugs.
DGI Kingston, DJ Newman
Current Opinion in Drug Discovery & Development 2002, 5:304-316 (12March2002)
[PDF] [PubMed] [Related articles]
Erratum: William Bains, Richard Gilbert, Lilya Sviridenko, Jose-Miguel Gascon, Robert Scoffin, Kris Birchall, Lesley Hetherington, Inman Harvey & John Caldwell: Evolutionary computational methods to predict oral bioavailability QSPRs. Curr Opin Drug Discovery Dev (2002) 5(1):44-51.
Current Opinion in Drug Discovery & Development 2002, 5:317 (12March2002)
[PDF]
Paper alert
J Hirst, P Norman, DP Rotella
Current Opinion in Drug Discovery & Development 2002, 5:319-338 (14May2002)
[PDF]
Patent alert
B Swords
Current Opinion in Drug Discovery & Development 2002, 5:339-351 (14May2002)
[PDF]
The management of chemical and biological information
D Cavalla
Current Opinion in Drug Discovery & Development 2002, 5:352-353 (14May2002)
[PDF] [PubMed] [Related articles]
Discovery systems integration: Is it strategic or tactical?
P Gund, F Brown, E Maliski
Current Opinion in Drug Discovery & Development 2002, 5:354 (14May2002)
[PDF]
Global analysis of large-scale chemical and biological experiments
DE Root, BP Kelley, BR Stockwell
Current Opinion in Drug Discovery & Development 2002, 5:355-360 (14May2002)
[PDF] [PubMed] [Related articles]
Component architecture in drug discovery informatics
PM Smith
Current Opinion in Drug Discovery & Development 2002, 5:361-366 (14May2002)
[PDF] [PubMed] [Related articles]
Structural genomics: Bridging functional genomics and structure-based drug design
SG Buchanan
Current Opinion in Drug Discovery & Development 2002, 5:367-381 (14May2002)
[PDF] [PubMed] [Related articles]
Progress in computational methods for the prediction of ADMET properties
DE Clark, PDJ Grootenhuis
Current Opinion in Drug Discovery & Development 2002, 5:382-390 (14May2002)
[PDF] [PubMed] [Related articles]
Fragment analysis in small molecule discovery
C Meriot, D Domine, DJ Church
Current Opinion in Drug Discovery & Development 2002, 5:391-399 (14May2002)
[PDF] [PubMed] [Related articles]
Knowledge-based approaches in the design and selection of compound libraries for drug discovery
VN Viswanadhan, C Balan, C Hulme, JC Cheetham, Y Sun
Current Opinion in Drug Discovery & Development 2002, 5:400-406 (14May2002)
[PDF] [PubMed] [Related articles]
Structure-based approaches to drug design and virtual screening
B Waszkowycz
Current Opinion in Drug Discovery & Development 2002, 5:407-413 (14May2002)
[PDF] [PubMed] [Related articles]
High-throughput virtual screening for drug discovery in parallel
LM Toledo-Sherman, D Chen
Current Opinion in Drug Discovery & Development 2002, 5:414-421 (14May2002)
[PDF] [PubMed] [Related articles]
Initial compound selection for sequential screening
SS Young, RLH Lam, WJ Welch
Current Opinion in Drug Discovery & Development 2002, 5:422-427 (14May2002)
[PDF] [PubMed] [Related articles]
Multiscale and Bayesian approaches to data analysis in genomics high- throughput screening
C Yang, BR Bakshi, JF Rathman, PE Blower
Current Opinion in Drug Discovery & Development 2002, 5:428-438 (14May2002)
[PDF] [PubMed] [Related articles]
Paper alert
J Hirst, P Norman, DP Rotella
Current Opinion in Drug Discovery & Development 2002, 5:439-458 (31July2002)
[PDF]
Patent alert
B Swords
Current Opinion in Drug Discovery & Development 2002, 5:459-472 (31July2002)
[PDF]
Web alert
D Cavalla
Current Opinion in Drug Discovery & Development 2002, 5:473-474 (31July2002)
[PDF] [PubMed] [Related articles]
Chemical genomics, pharmacogenomics and pharmacogenetics.
WJ Greenlee, MC Desai
Current Opinion in Drug Discovery & Development 2002, 5:475-476 (31July2002)
[PDF]
Osteoporosis: Challenges and new opportunities for therapy.
DP Rotella
Current Opinion in Drug Discovery & Development 2002, 5:477-486 (31July2002)
[PDF] [PubMed] [Related articles]
Recent advances in the discovery of small molecule histone deacetylase inhibitors.
SW Remiszewski
Current Opinion in Drug Discovery & Development 2002, 5:487-499 (31July2002)
[PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes.
JF Tobin, S Tam
Current Opinion in Drug Discovery & Development 2002, 5:500-512 (31July2002)
[PDF] [PubMed] [Related articles]
Recent advances in the development of g-secretase inhibitors.
H Josien
Current Opinion in Drug Discovery & Development 2002, 5:513-525 (31July2002)
[PDF] [PubMed] [Related articles]
Drug discovery and development using chemical genomics.
A Sehgal
Current Opinion in Drug Discovery & Development 2002, 5:526-531 (31July2002)
[PDF] [PubMed] [Related articles]
Chemical genomics: Bridging the gap between the proteome and therapeutics.
D Falb, S Jindal
Current Opinion in Drug Discovery & Development 2002, 5:532-539 (31July2002)
[PDF] [PubMed] [Related articles]
Guiding molecules towards drug-likeness.
WJ Egan, WP Walters, MA Murcko
Current Opinion in Drug Discovery & Development 2002, 5:540-549 (31July2002)
[PDF] [PubMed] [Related articles]
Designing selective COX-2 inhibitors: Molecular modeling approaches.
G Trummlitz, Ryn J van
Current Opinion in Drug Discovery & Development 2002, 5:550-561 (31July2002)
[PDF] [PubMed] [Related articles]
Microsomal triglyceride transfer protein (MTP) inhibitors: Discovery of clinically active inhibitors using high-throughput screening and parallel synthesis paradigms.
G Chang, RB Ruggeri, Jr HJ Harwood
Current Opinion in Drug Discovery & Development 2002, 5:562-570 (31July2002)
[PDF] [PubMed] [Related articles]
New developments in chemical library synthesis. Norbornenyl tags for use in phase-switching,
sequestration, capture-release and soluble support applications.
DL Flynn, PR Hanson, SC Berk, GM Makara
Current Opinion in Drug Discovery & Development 2002, 5:571-579 (31July2002)
[PDF] [PubMed] [Related articles]
Recent advances in chemical library synthesis methodology.
DL Flynn, SC Berk, GM Makara
Current Opinion in Drug Discovery & Development 2002, 5:580-593 (31July2002)
[PDF] [PubMed] [Related articles]
Solid-phase compound library synthesis in drug design and development.
PJ Edwards, AI Morrell
Current Opinion in Drug Discovery & Development 2002, 5:594-605 (31July2002)
[PDF] [PubMed] [Related articles]
Membrane array technology for drug discovery.
JT Groves
Current Opinion in Drug Discovery & Development 2002, 5:606-612 (31July2002)
[PDF] [PubMed] [Related articles]
Using X-ray crystallography in drug discovery.
RS Rowland
Current Opinion in Drug Discovery & Development 2002, 5:613-619 (31July2002)
[PDF] [PubMed] [Related articles]
Recent trends in microwave-assisted synthesis.
NS Wilson, GP Roth
Current Opinion in Drug Discovery & Development 2002, 5:620-629 (31July2002)
[PDF] [PubMed] [Related articles]
NMR-based approaches for lead discovery.
DF Wyss, MA McCoy, MM Senior
Current Opinion in Drug Discovery & Development 2002, 5:630-647 (31July2002)
[PDF] [PubMed] [Related articles]
Paper alert
J Hirst, P Norman, DP Rotella
Current Opinion in Drug Discovery & Development 2002, 5:649-667 (18September2002)
[PDF]
Patent alert
B Swords
Current Opinion in Drug Discovery & Development 2002, 5:668-678 (18September2002)
[PDF]
Web alert
D Cavalla
Current Opinion in Drug Discovery & Development 2002, 5:679-680 (18September2002)
[PDF]
The chemistry of biological processes.
JA Lowe, CH Hill, FD King
Current Opinion in Drug Discovery & Development 2002, 5:681-682 (18September2002)
[PDF]
Integrated approaches to therapeutic target gene discovery.
KM DeFife, F Wong-Staal
Current Opinion in Drug Discovery & Development 2002, 5:683-689 (18September2002)
[PDF] [PubMed] [Related articles]
Aptamers and aptazymes: Accelerating small molecule drug discovery.
P Burgstaller, A Jenne, M Blind
Current Opinion in Drug Discovery & Development 2002, 5:690-700 (18September2002)
[PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Targeting protein kinases in cancer therapy.
D Fabbro, C Garcia-Echeverria
Current Opinion in Drug Discovery & Development 2002, 5:701-712 (18September2002)
[PDF] [PubMed] [Related articles]
Kinases as targets: Prospects for chronic therapy.
S Orchard
Current Opinion in Drug Discovery & Development 2002, 5:713-717 (18September2002)
[PDF] [PubMed] [Related articles]
Protein kinase inhibitors from the urea class.
J Dumas
Current Opinion in Drug Discovery & Development 2002, 5:718-727 (18September2002)
[PDF] [PubMed] [Related articles]
Bioactive lipids and their receptors.
I Angel, A Bar, R Haring
Current Opinion in Drug Discovery & Development 2002, 5:728-740 (18September2002)
[PDF] [PubMed] [Related articles]
The inner workings of AMPA receptors.
DR Madden
Current Opinion in Drug Discovery & Development 2002, 5:741-748 (18September2002)
[PDF] [PubMed] [Related articles]
Allosteric modulation of G protein-coupled receptors.
W Soudjin, Wijngaarden I van, AP IJzerman
Current Opinion in Drug Discovery & Development 2002, 5:749-755 (18September2002)
[PDF] [PubMed] [Related articles]
Formation of oligomers by G protein-coupled receptors.
L Gazi, JF Lopez-Gimenez, PG Strange
Current Opinion in Drug Discovery & Development 2002, 5:756-763 (18September2002)
[PDF] [PubMed] [Related articles]
Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes.
P Kitabgi
Current Opinion in Drug Discovery & Development 2002, 5:764-776 (18September2002)
[PDF] [PubMed] [Related articles]
Internal initiation of translation by viral and cellular IRESs - A new avenue for specific inhibition of protein synthesis?
J Gallego
Current Opinion in Drug Discovery & Development 2002, 5:777-784 (18September2002)
[PDF] [PubMed] [Related articles]
Novel approaches to antimicrobial therapy: Peptide deformylase.
AS Waller, JM Clements
Current Opinion in Drug Discovery & Development 2002, 5:785-792 (18September2002)
[PDF] [PubMed] [Related articles]
New approaches to reversal of neuromuscular block.
A Bom, JK Clark, R Palin
Current Opinion in Drug Discovery & Development 2002, 5:793-800 (18September2002)
[PDF] [PubMed] [Related articles]
Paper alert
J Hirst, P Norman, DP Rotella
Current Opinion in Drug Discovery & Development 2002, 5:801-817 (20November2002)
[PDF]
Patent alert
B Swords
Current Opinion in Drug Discovery & Development 2002, 5:818-829 (20November2002)
[PDF]
Web alert
D Cavalla
Current Opinion in Drug Discovery & Development 2002, 5:830-831 (20November2002)
[PDF] [PubMed] [Related articles]
Editorial overview
RN Landau, PN Confalone, JA Grosso
Current Opinion in Drug Discovery & Development 2002, 5:832-833 (20November2002)
[PDF]
Scalable enantioselective processes for chiral pharmaceutical intermediates.
T Lida, T Mase
Current Opinion in Drug Discovery & Development 2002, 5:834-851 (20November2002)
[PDF] [PubMed] [Related articles]
Development of an atropselective methodology for axially chiral biaryls in the asymmetric synthesis of A-240610.0.
Y Ku, T Grieme
Current Opinion in Drug Discovery & Development 2002, 5:852-859 (20November2002)
[PDF] [PubMed] [Related articles]
Catalytic enantioselective oxidations using molecular oxygen.
MS Sigman, DR Jensen, S Rajaram
Current Opinion in Drug Discovery & Development 2002, 5:860-869 (20November2002)
[PDF] [PubMed] [Related articles]
Synthetic applications of chiral 2,3-dihydro-4-pyridones.
S Joseph, DL Comins
Current Opinion in Drug Discovery & Development 2002, 5:870-880 (20November2002)
[PDF] [PubMed] [Related articles] [Cited on BioMed Central]
New methodology for the asymmetric reduction of ketones.
M Wills, J Hannedouche
Current Opinion in Drug Discovery & Development 2002, 5:881-891 (20November2002)
[PDF] [PubMed] [Related articles]
Asymmetric hydrogenation and other methods for the synthesis of unnatural amino acids and derivatives.
DJ Ager
Current Opinion in Drug Discovery & Development 2002, 5:892-905 (20November2002)
[PDF] [PubMed] [Related articles]
Selective functionalization of small organic molecules using electrophilic nitrogen sources.
IDG Watson, AK Yudin
Current Opinion in Drug Discovery & Development 2002, 5:906-917 (20November2002)
[PDF] [PubMed] [Related articles]
Aziridines and aziridinium ions in the practical synthesis of pharmaceutical intermediates - A perspective.
VH Dahanukar, LA Zavialov
Current Opinion in Drug Discovery & Development 2002, 5:918-927 (20November2002)
[PDF] [PubMed] [Related articles]
Stereoselective transition metal-catalyzed and radical polycyclizations.
C Aubert, C Courillon, A Dhimane, L Fensterbank, E Lacote, S Thorimbert, M Malacria
Current Opinion in Drug Discovery & Development 2002, 5:928-936 (20November2002)
[PDF] [PubMed] [Related articles]
Heavy-metal complexation by de novo peptide design.
BT Farrer, VL Pecoraro
Current Opinion in Drug Discovery & Development 2002, 5:937-943 (20November2002)
[PDF] [PubMed] [Related articles]
Synthetic approaches to the microtubule stabilizing agent (-)-laulimalide.
MT Crimmins
Current Opinion in Drug Discovery & Development 2002, 5:944-959 (20November2002)
[PDF] [PubMed] [Related articles]
Scale-up of polymerization processes.
T Meyer
Current Opinion in Drug Discovery & Development 2002, 5:960-965 (20November2002)
[PDF] [PubMed] [Related articles]
Heterogeneously functionalized dendrimers.
JR Morgan, MJ Cloninger
Current Opinion in Drug Discovery & Development 2002, 5:966-973 (20November2002)
[PDF] [PubMed] [Related articles]
Selective RXR modulators for the treatment of type II diabetes.
MM Faul, TA Grese
Current Opinion in Drug Discovery & Development 2002, 5:974-985 (20November2002)
[PDF] [PubMed] [Related articles]
Recent developments in the construction of trans-fused polycyclic ethers.
PA Evans, B Delouvrie
Current Opinion in Drug Discovery & Development 2002, 5:986-999 (20November2002)
[PDF] [PubMed] [Related articles]
Innovative oxidation methods in fine chemicals synthesis.
P Poechlauer, W Skranc
Current Opinion in Drug Discovery & Development 2002, 5:1000-1008 (20November2002)
[PDF] [PubMed] [Related articles]
Erratum
Current Opinion in Drug Discovery & Development 2002, 5:1009 (20November2002)
[PDF]
|
|
| 
Current Opinion in Drug Discovery & Development Volumes |
| | |
|
previous issue